Selenium suppressed growth of Ehrlich solid tumor and improved health of tumor-bearing mice.
Autor: | Hekal HA; Faculty of Science, Mansoura University, Mansoura, Egypt., Amer ME; Faculty of Science, Mansoura University, Mansoura, Egypt., Amer M; Faculty of Science, Mansoura University, Mansoura, Egypt., El-Missiry MA; Faculty of Science, Mansoura University, Mansoura, Egypt., Othman AI; Faculty of Science, Mansoura University, Mansoura, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of experimental zoology. Part A, Ecological and integrative physiology [J Exp Zool A Ecol Integr Physiol] 2024 Jul; Vol. 341 (6), pp. 672-682. Date of Electronic Publication: 2024 Apr 09. |
DOI: | 10.1002/jez.2815 |
Abstrakt: | Selenium (Se) is an important micronutritional biomolecule in cancer therapy. The current work evaluated the anticancer effect of Se and its ability to improve health of mice with solid Ehrlich carcinoma implanted subcutaneously. Four groups of five female BALB/c mice each were assembled. Ehrlich tumor cells were engrafted into two of them, either with or without Se therapy. The other groups served as control groups, either with or without Se treatment. Se treatment resulted in a notable decrease in both tumor volume and animal body mass in tumor-bearing mice. Treatment with Se markedly increased oxidative stress in tumor while ameliorating oxidative stress in sera of tumors-bearing mice. Similarly, treatment with Se resulted in downregulation of inflammatory cytokines (TNF-α and IL-6) while increasing IL-10 in serum of tumor-bearing mice. Conversely, selenium increased TNF- α and IL-6 and decreased IL-10 in tumor suggesting disruption of tumor immunity. The increased oxidative stress and inflammation in tumor tissue dysregulated cell cycle phases with increase apoptotic tumor cells population in G (© 2024 Wiley Periodicals LLC.) |
Databáze: | MEDLINE |
Externí odkaz: |